arginine has been researched along with gv 150013x in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonioli, L; Baschiera, F; Blandizzi, C; Buccianti, P; Chiarugi, M; Colucci, R; Crema, F; Del Tacca, M; Fornai, M; Ghisu, N; Tuccori, M | 1 |
1 other study(ies) available for arginine and gv 150013x
Article | Year |
---|---|
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway.
Topics: Adamantane; Arginine; Colon; Dose-Response Relationship, Drug; Electric Stimulation; Gastrointestinal Motility; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nootropic Agents; Phenylurea Compounds; Potassium Chloride; Receptor, Cholecystokinin B; Sincalide; Tetrodotoxin | 2007 |